Tumor Necrosis Factor and Interleukin-1 Lead to Phosphorylation and Loss of IκBα: a Mechanism for NF-κB Activation

REFERENCES

• Badley, J. E., G. A. Bishop, T. St. John, and J. A. Frelinger. 1988. A simple, rapid method for the purification of poly A+ RNA. BioTechniques 6:114–116.
   PubMed Web of Science ®Google Scholar
• Baeuerle, P. A., and D. Baltimore. 1988. Activation of DNA binding activity in an apparently cytoplasmic precursor of the NFκB transcription factor. Cell 53:211–217.
   PubMed Web of Science ®Google Scholar
• Baeuerle, P. A., and D. Baltimore. 1988. IκB: a specific inhibitor of the NFκB transcription factor. Science 242:540–546.
   PubMed Web of Science ®Google Scholar
• Baeuerle, P. A., and D. Baltimore. 1989. A 65-kD subunit of active NF-κB is required for inhibition of NF-κB by IκB. Genes Dev. 3:1689–1698.
   PubMed Web of Science ®Google Scholar
• Baeuerle, P. A., and D. Baltimore. 1991. The physiology of the NF-κB transcription factor, p. 409–432. In P. Cohen and J. G. Foulkes (ed.), Hormonal control regulation of gene expression. Biomedical Press, Elsevier/North Holland, Amsterdam.
   Google Scholar
• Ballard, D. W., E. P. Dixon, N. J. Peffer, H. Bogerd, S. Doerre, B. Stein, and W. C. Greene. 1992. The 65-kDa subunit of human NF-κB functions as a potent transcriptional activator and a target for v-Rel-mediated repression. Proc. Natl. Acad. Sci. USA 89:1875–1879.
   PubMedGoogle Scholar
• Ballard, D. W., W. H. Walker, S. Doerre, P. Sista, J. A. Molitor, E. P. Dixon, N. J. Peffer, M. Hannink, and W. C. Greene. 1990. The v-rel oncogene encodes a κB enhancer binding protein that inhibits NF-κB function. Cell 63:803–814.
   PubMed Web of Science ®Google Scholar
• Beg, A. A., et al. Unpublished data.
   Google Scholar
• Beg, A. A., S. M. Ruben, R. I. Scheinman, S. Haskill, C. A. Rosen, and A. S. Baldwin, Jr. 1992. IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention. Genes Dev. 6:1899–1913.
   PubMed Web of Science ®Google Scholar
• Blank, V., P. Kourilsky, and A. Israel. 1991. Cytoplasmic retention, DNA binding and processing of the NF-κB p50 precursor are controlled by a small region in its C-terminus. EMBO J. 10:4159–4167.
   PubMed Web of Science ®Google Scholar
• Bomsztyk, K., J. W. Rooney, T. Iwasaki, N. A. Rachie, S. K. Dower, and C. H. Sibley. 1991. Evidence that interleukin-1 and phorbol esters activate NF-κB by different pathways: role of protein kinase C. Cell Regul. 2:329–335.
   PubMedGoogle Scholar
• Bours, V., J. Villalobos, P. R. Burd, K. Kelly, and U. Siebenlist. 1990. Cloning of a mitogen-inducible gene encoding a κB DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs. Nature (London) 348:76–80.
   PubMed Web of Science ®Google Scholar
• Brownell, E., N. Mittereder, and N. R. Rice. 1989. A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon. Oncogene 4:935–942.
   PubMed Web of Science ®Google Scholar
• Davis, N., S. Ghosh, D. L. Simmons, P. Tempst, H.-C. Liou, D. Baltimore, and H. R. Bose, Jr. 1991. Rel-associated pp40: an inhibitor of the Rel family of transcription factors. Science 253:1268–1271.
   PubMedGoogle Scholar
• Dinarello, C. A. 1991. Interleukin-1 and interleukin-1 antagonism. Blood 77:1627–1652.
   PubMed Web of Science ®Google Scholar
• Dressier, K. A., S. Mathias, and R. N. Kolesnick. 1992. Tumor necrosis factor-α activates the sphingomyelin signal transduction pathway in a cell-free system. Science 255:1715–1718.
   PubMed Web of Science ®Google Scholar
• Duh, E. J., W. J. Maury, T. M. Folks, A. S. Fauci, and A. B. Rabson. 1989. Tumor necrosis factor α activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat. Proc. Natl. Acad. Sci. USA 86:5974–5978.
   PubMed Web of Science ®Google Scholar
• Fan, C.-M., and T. Maniatis. 1991. Generation of p50 subunit of NF-κB by processing of pl05 through an ATP-dependent pathway. Nature (London) 354:395–398.
   PubMed Web of Science ®Google Scholar
• Feuillard, J., H. Gouy, G. Bismuth, L. M. Lee, P. Debre, and M. Korner. 1991. NF-κB activation by tumor necrosis factor α in the Jurkat T cell line is independent of protein kinase A, protein kinase C, and Ca2+-regulated kinases. Cytokine 3:257–265.
   PubMedGoogle Scholar
• Franzoso, G., V. Bours, S. Park, M. Tomita-Yamaguchi, K. Kelly, and U. Siebenlist. 1992. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition. Nature (London) 359:339–342.
   PubMedGoogle Scholar
• Ghosh, S., and D. Baltimore. 1990. Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB. Nature (London) 344:678–682.
   PubMed Web of Science ®Google Scholar
• Ghosh, S., A. M. Gifford, L. R. Riviere, P. Tempst, G. P. Nolan, and D. Baltimore. 1990. Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal. Cell 62:1019–1029.
   PubMed Web of Science ®Google Scholar
• Grilli, M., J. S. Chiu, and M. J. Lenardo. 1993. NF-κB and Rel—participants in a multiform transcriptional regulatory sys-tem. Int. Rev. Cytol. 143:1–62.
   PubMed Web of Science ®Google Scholar
• Haskill, S., A. A. Beg, S. M. Tompkins, J. S. Morris, A. D. Yurochko, A. Sampson-Johannes, K. Mondai, P. Ralph, and A. S. Baldwin, Jr. 1991. Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell 65:1281–1289.
   PubMed Web of Science ®Google Scholar
• Hatada, E. N., A. Nieters, F. G. Wulczyn, M. Naumann, R. Meyer, G. Nucifora, T. W. McKeithan, and C. Scheidereit. 1992. The ankyrin repeat domains of the NF-κB precursor pl05 and the proto-oncogene bcl-3 act as specific inhibitors of NF-κB DNA binding. Proc. Natl. Acad. Sci. USA 89:2489–2493.
   PubMedGoogle Scholar
• Henkel, T., U. Zabel, K. van Zee, J. M. Müller, E. Fanning, and P. A. Baeuerle. 1992. Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-κB subunit. Cell 68:1121–1133.
   PubMed Web of Science ®Google Scholar
• Hohmann, H.-P., R. Remy, C. Scheidereit, and A. P. G. M. van Loon. 1991. Maintenance of NF-κB activity is dependent on protein synthesis and the continuous presence of external stimuli. Mol. Cell. Biol. 11:259–266.
   PubMedGoogle Scholar
• Inoue, J.-L, L. D. Kerr, A. Kakizuka, and I. M. Verma. 1992. IκBγ, a 70 kd protein identical to the C-terminal half of p110 NF-κB: a new member of the IκB family. Cell 68:1109–1120.
   PubMed Web of Science ®Google Scholar
• Inoue, J.-L, L. D. Kerr, D. Rashid, N. Davis, H. R. Bose, Jr., and I. M. Verma. 1992. Direct association of pp40/IκBβ with rel/NF-κB transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity. Proc. Natl. Acad. Sci. USA 89:4333–4337.
   PubMedGoogle Scholar
• Israël, A., O. Le Bail, D. Hatat, J. Piette, M. Kieran, F. Logeat, D. Wallach, M. Fellous, and P. Kourilsky. 1989. TNF stimulates expression of mouse MHC class I genes by inducing an NF-κB-like enhancer binding activity which displaces constitutive fac-tors. EMBO J. 8:3793–3800.
   PubMedGoogle Scholar
• Ito, C., and A. S. Baldwin. Unpublished observations.
   Google Scholar
• Kerr, L. D., J.-I. Inoue, N. Davis, E. Link, P. A. Baeuerle, H. A. J Bose, and I. M. Verma. 1991. The Rel-associated pp40 protein prevents DNA binding of Rel and NF-κB: relationship with IκBβ and regulation by phosphorylation. Genes Dev. 5:1464–1476.
   PubMedGoogle Scholar
• Kieran, M., V. Blank, F. Logeat, J. Vandekerckhove, F. Lottspeich, O. Le Bail, M. Urban, P. Kourilsky, P. A. Baeuerle, and A. Israël. 1990. The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell 62:1007–1018.
   PubMed Web of Science ®Google Scholar
• Kunsch, C., S. M. Ruben, and C. A. Rosen. 1992. Selection of optimal κB/Rel DNA-binding motifs: interaction of both sub-units of NF-κB with DNA is required for transcriptional activation. Mol. Cell. Biol. 12:4412–4421.
   PubMed Web of Science ®Google Scholar
• Lowenthal, J. W., D. W. Ballard, E. Böhnlein, and W. C. Greene. 1989. Tumor necrosis factor α induces proteins that bind specifically to κB-like enhancer elements and regulate interleukin 2 receptor α-chain gene expression in primary human T lymphocytes. Proc. Natl. Acad. Sci. USA 86:2331–2335.
   PubMedGoogle Scholar
• Mathias, S., K. A. Dressier, and R. N. Kolesnick. 1991. Characterization of a ceramide-activated protein kinase: stimulation by tumor necrosis factor α. Proc. Natl. Acad. Sci. USA 88:10009–10013.
   PubMedGoogle Scholar
• Nolan, G. P., and D. Baltimore. 1992. The inhibitory ankyrin and activator Rel proteins. Curr. Opin. Genet. Dev. 2:211–224.
   PubMed Web of Science ®Google Scholar
• Nolan, G. P., S. Ghosh, H.-C. Liou, P. Tempst, and D. Baltimore. 1991. DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide. Cell 64:961–969.
   PubMed Web of Science ®Google Scholar
• Osborn, L., S. Kunkel, and G. J. Nabel. 1989. Tumor necrosis factor α and interleukin 1 stimulate the human immunodefi-ciency virus enhancer by activation of the nuclear factor κB. Proc. Natl. Acad. Sci. USA 86:2336–2340.
   PubMed Web of Science ®Google Scholar
• Rice, N. R., M. L. MacKichan, and A. Israël. 1992. The precursor of NF-κB p50 has IκB-like functions. Cell 71:243–253.
   PubMedGoogle Scholar
• Ruben, S. M., P. J. Dillon, R. Schreck, T. Henkel, C.-H. Chen, M. Maher, P. A. Baeuerle, and C. A. Rosen. 1991. Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-κB. Science 251:1490–1493.
   PubMedGoogle Scholar
• Ruben, S. M., R. Narayanan, J. F. Klement, C.-H. Chen, and C. A. Rosen. 1992. Functional characterization of the NF-κB p65 transcriptional activator and an alternatively spliced derivative. Mol. Cell. Biol. 12:444–454.
   PubMedGoogle Scholar
• Schreck, R., B. Meier, D. N. Männel, W. Dröge, and P. A. Baeuerle. 1992. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J. Exp. Med. 175:1181–1194.
   PubMed Web of Science ®Google Scholar
• Schreck, R., P. Rieber, and P. A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:2247–2258.
   PubMed Web of Science ®Google Scholar
• Schütze, S., K. Potthoff, T. Machleidt, D. Berkovic, K. Wiegmann, and M. Krönke. 1992. TNF activates NF-κB by phos-phatidylcholine-specific phospholipase C-induced “acidic” sphingomyelin breakdown. Cell 71:765–776.
   PubMed Web of Science ®Google Scholar
• Shirakawa, F., and S. Mizel. 1989. In vitro activation and nuclear translocation of NF-κB catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol. Cell. Biol. 9:2424–2430.
   PubMed Web of Science ®Google Scholar
• Staal, F. J. T., M. Roederer, L. A. Herzenberg, and L. A. Herzenberg. 1990. Intracellular thiols regulate activation of the nuclear factor κB and transcription of the human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 87:9943–9947.
   PubMed Web of Science ®Google Scholar
• Stein, B., H. J. Rahmsdorf, A. Steffen, M. Litfin, and P. Herrlich. 1989. UV-induced DNA damage is an intermediate in the UV-induced expression of human immunodeficiency virus type 1 (HIV-1), collagenase, c-fos and metallothionein. Mol. Cell. Biol. 9:5169–5181.
   PubMed Web of Science ®Google Scholar
• Storms, R. W., and H. R. Bose. 1992. Alterations within pp59v-rel-containing protein complexes following the stimulation of REV-T-transformed lymphoid cells with zinc. Virology 188:765–777.
   PubMedGoogle Scholar
• Tan, T.-H., G. P. Huang, A. Sica, P. Ghosh, H. A. Young, D. L. Longo, and N. R. Rice. 1992. κB site-dependent activation of the interleukin-2 receptor α-chain gene promoter by human c-Rel. Mol. Cell. Biol. 12:4067–4075.
   PubMedGoogle Scholar
• Ten, R. M., C. V. Paya, N. Israël, O. Le Bail, M.-G. Mattei, J.-L. Virelizier, P. Kourilsky, and A. Israël. 1992. The charac-terization of the promoter of the gene encoding the p50 subunit of NF-κB indicates that it participates in its own regulation. EMBO J. 11:195–203.
   PubMed Web of Science ®Google Scholar
• Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411–452.
   PubMed Web of Science ®Google Scholar
• Wulczyn, F. G., M. Naumann, and C. Scheidereit. 1992. Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-κB. Nature (London) 358:597–599.
   PubMedGoogle Scholar